You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Glomerulonephritis, IGA

Showing 1 - 25 of 446
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hyperspectral Imaging in the Diagnosis of Glomerular Diseases

Not yet recruiting
  • Glomerulonephritis, IGA
  • +4 more
  • Microscopic hyperspectral imaging system
  • (no location specified)
Mar 31, 2023

Glomerulonephritis, IGA Trial in Besançon (Blood collection, Urine sample)

Not yet recruiting
  • Glomerulonephritis, IGA
  • Blood collection
  • Urine sample
  • Besançon, France
    Centre Hospitalier Universitaire de Besançon
Mar 17, 2023

Primary IgA Nephropathy Trial (HRS-5965, Placebo)

Not yet recruiting
  • Primary IgA Nephropathy
  • (no location specified)
Nov 14, 2023

Glomerulonephritis, IGA Trial (Prednisolone, Prednisolone plus Cyclophosphamide)

Not yet recruiting
  • Glomerulonephritis, IGA
  • (no location specified)
Aug 19, 2022

IgA Nephropathy, Immunoglobulin A Nephropathy Trial (BION-1301, Placebo)

Not yet recruiting
  • IgA Nephropathy
  • Immunoglobulin A Nephropathy
  • (no location specified)
May 2, 2023

Primary IgA Nephropathy Trial (SHR-2010 Injection, Placebo)

Not yet recruiting
  • Primary IgA Nephropathy
  • SHR-2010 Injection
  • Placebo
  • (no location specified)
Apr 27, 2023

IgA Nephropathy Trial (CM338)

Not yet recruiting
  • IgA Nephropathy
  • CM338
  • (no location specified)
Mar 7, 2023

IgA Nephropathy, Immunoglobulin A Nephropathy Trial (Atrasentan, Placebo)

Not yet recruiting
  • IgA Nephropathy
  • Immunoglobulin A Nephropathy
  • (no location specified)
Apr 27, 2023

Bortezomib, Glomerulonephritis, MN Trial in Shanghai (Bortezomib)

Recruiting
  • Bortezomib
  • +5 more
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
Oct 28, 2022

IgA Nephropathy Trial in Hangzhou (Telitacicept, Placebo)

Not yet recruiting
  • IgA Nephropathy
  • Hangzhou, Zhejiang, China
    The Second Affiliated Hospital of Zhejiang University School of
Oct 25, 2022

Primary IgA Nephropathy Trial (RO7434656, Placebo)

Not yet recruiting
  • Primary IgA Nephropathy
  • (no location specified)
Mar 22, 2023

Link Between Complement Activation and IgA Nephropathy Severity

Recruiting
  • IgA Nephropathy Severity in Kidney Transplantation
  • IgAN patients
  • Strasbourg, France
    Service de néphrologie
Aug 18, 2022

IgA Nephropathy Trial in Shanghai

Recruiting
  • IgA Nephropathy
    • Shanghai, Shanghai, China
      Ruijin Hospital, Shanghai JiaoTong University School of Medicine
    Nov 1, 2022

    Primary IgA Nephrology Trial in Beijing (Nefecon)

    Not yet recruiting
    • Primary IgA Nephrology
    • Beijing, Beijing, China
      Peking University First Hospital
    Sep 6, 2022

    Lupus Nephritis, Immunoglobulin A Nephropathy, Membranous Nephropathy Trial (povetacicept)

    Not yet recruiting
    • Lupus Nephritis
    • +2 more
    • (no location specified)
    Feb 16, 2023

    IgA Nephropathy, Focal Segmental Glomerulosclerosis Trial in Nanjing (HS-10390 tablet, Placebo tablet)

    Recruiting
    • IgA Nephropathy
    • Focal Segmental Glomerulosclerosis
    • HS-10390 tablet
    • Placebo tablet
    • Nanjing, Jiangsu, China
      Zhongda Hospital, Affiliated to Southeast University
    Jul 12, 2023

    IgA Nephropathy Trial in Shanghai (rituximab group)

    Active, not recruiting
    • IgA Nephropathy
    • rituximab group
    • Shanghai, Shanghai, China
      Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
    Apr 9, 2023

    IgA Nephropathy (IgAN), Berger Disease, Glomerulonephritis, IgA Trial in Worldwide (Placebo, Cemdisiran)

    Active, not recruiting
    • IgA Nephropathy (IgAN)
    • +2 more
    • Vancouver, British Columbia, Canada
    • +19 more
    Jan 13, 2023

    Diabetic Kidney Disease, IgA Nephropathy Trial (Placebo of SC0062, SC0062 low dose, SC0062 medium dose)

    Not yet recruiting
    • Diabetic Kidney Disease
    • IgA Nephropathy
    • Placebo of SC0062
    • +3 more
    • (no location specified)
    Jan 9, 2023

    Immunoglobulin A Nephropathy, Kidney Diseases, Glomerulonephritis, IGA Trial in Leicester (Sparsentan)

    Recruiting
    • Immunoglobulin A Nephropathy
    • +5 more
    • Leicester, United Kingdom
      Leicester General Hospital, University Hospitals of Leicester NH
    May 18, 2022

    Kidney Diseases, Kidney Failure, Chronic, Diabetic Nephropathy Trial in New York

    Recruiting
    • Kidney Diseases
    • +4 more
      • New York, New York
        The Rogosin Institute
      Feb 28, 2022

      IgA Nephropathy Trial in Xi'an (education and monitoring)

      Recruiting
      • IgA Nephropathy
      • education and monitoring
      • Xi'an, Shaanxi, China
        First affiliated hospital of Xi'an Jiaotong University
      Apr 26, 2022

      Glomerulonephritis, IGA, Kidney Diseases, Acute Renal Insufficiency Trial in Beijing (Plasma Exchange (PE), Methylprednisolone

      Terminated
      • Glomerulonephritis, IGA
      • +3 more
      • Plasma Exchange (PE)
      • Methylprednisolone pulse
      • Beijing, Beijing, China
      • +1 more
      Sep 30, 2021

      Immunoglobulin A Nephropathy Trial in Denver (Sparsentan)

      Not yet recruiting
      • Immunoglobulin A Nephropathy
      • Denver, Colorado
        Travere Investigational Site
      May 12, 2023

      Glomerulonephritis , IGA Trial in Kasugai, Nagoya (infusion of ADR-001 (Mesenchymal stem cell))

      Active, not recruiting
      • Glomerulonephritis , IGA
      • infusion of ADR-001 (Mesenchymal stem cell)
      • Kasugai, Aichi, Japan
      • +1 more
      Nov 10, 2021